Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

229 studies match

clinicaltrialsPublishedShowing 51–100 of 229 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06611839	Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML(IDH1-AML-2024)	recruiting	Phase 1 / Phase 2	23	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	May 13, 2026	clinicaltrials
NCT06635681	Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML(DAV-AML-2024)	recruiting	Phase 2	380	Institute of Hematology & Blood Diseases Hospital, China